Link between NT-proBNP and heart artery disease
Part of Heart & circulation, Pain clinical trials.
This study looks at a blood test called NT-proBNP to see if it can help predict how much blockage is in the heart's arteries. It may help doctors better understand heart disease risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for a heart catheterization to check for blocked arteries.
- You have a blood test for NT-proBNP while in the hospital.
- You do not have heart failure, severe valve disease, or atrial fibrillation.
- You do not have severe kidney disease (eGFR below 30).
- You have not had bypass heart surgery before.
- You are 80 years old or younger.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is checking people over 40 who have a higher-than-average heart stress marker (NT-proBNP) to see if they have undiagnosed atrial fibrillation. You'll use a smartphone to track your heart rhythm at home.
This study looks at blood proteins and other molecules in people with different types of coronary artery disease. The goal is to see how these markers differ between those with blocked arteries, those with narrowed arteries, and those with no artery disease. This may help doctors better understand the disease and improve treatment.
This study looks at how well the right side of the heart works in people with chronic heart failure. It may help doctors understand why some people develop right heart problems and find better ways to treat them.
This trial tests if a hormone called BNP (a protein from the heart) can help doctors better understand your sudden heart problem. It may guide treatment or predict recovery.
This trial is testing a simple blood test (NT-proBNP) to find heart failure early in people who have symptoms but haven't been diagnosed yet. If the test levels are high, it could help doctors start treatment sooner.
This trial tests whether checking a blood marker called NT-proBNP at your bedside while in the hospital helps doctors better manage acute heart failure. It could lead to more personalized treatment and a clearer picture of your recovery.
Hear when a new Chronic Coronary Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.